Motility News

Nearly 7.5 million Americans are expected to reach their holiday destinations by plane this year — a daunting task for most individuals but even more challenging for those with gastrointestinal disorders.

Salix Pharmaceuticals has joined forces with the U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders to declare December 5 as Opioid-Induced Constipation Awareness Day, according to a company press release.

VANCOUVER, British Columbia — As-needed vagal nerve stimulation reduced rescue mediation use among patients with nausea related to gastroparesis or functional dyspepsia, according to data presented at the ACG Annual Scientific Meeting.

VANCOUVER, British Columbia — Continued Ibsrela therapy for 12 weeks enabled early nonresponders with irritable bowel syndrome and constipation to achieve a meaningful response, noted a presenter at the ACG Annual Scientific Meeting.

From the early days of homemade “poop shakes” blended in a backroom 15 years ago to the current world of FDA-approved live biotherapeutic products, it feels like we are at an inflection point with fecal microbiota transplantation.

In this Healio video exclusive, Imad Absah, MD, explains how an artificial intelligence-based algorithm helped accurately identify pediatric patients with known celiac disease, especially those who had not received adequate follow-up care.

Constipation is a relatively common problem in pediatric practice, with reported prevalence rates between 1% and 30%, as well as the chief complaint in 3% to 5% of visits to pediatric outpatient clinics. Because most constipation cases can be remedied through recommended over-the-counter laxatives, constipation is rarely a cause for severe worry among parents.

The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as well as increased risk for hypoglycemia if used in combination with insulin or insulin secretagogue.

Washed microbiota transplantation improved straining, hard stools and reduced stool frequency among patients with refractory functional constipation, with greater efficacy reported with additional courses of treatment.

Case-control and cohort analyses showed dysphasia, gastroparesis, irritable bowel syndrome without diarrhea and constipation may be associated with an increased risk for Parkinson’s disease, according to research in Gut.